Researchers are excited about this new drug, a novel dual compound showing promising data in initial trials for weight reduction . It works by impacting both hormones : GLP-1 and GIP, that , when stimulated, help influence hunger and boost energy expenditure . Preliminary observations indicate noteworthy weight loss and likely benefits for patients